MXPA03000063A - Ligandos para receptores de malanocortina. - Google Patents

Ligandos para receptores de malanocortina.

Info

Publication number: MXPA03000063A
Authority: MX; Mexico
Prior art keywords: melanocortin receptor; receptor ligands; melanocortin; het; disorders
Prior art date: 2000-06-28

Application number

MXPA03000063A

Other languages

English (en)

Inventor

Bradley Paul Morgan

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-28

Filing date

2001-05-31

Publication date

2003-09-25

2001-05-31 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-09-25 Publication of MXPA03000063A publication Critical patent/MXPA03000063A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

MXPA03000063A 2000-06-28 2001-05-31 Ligandos para receptores de malanocortina. MXPA03000063A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21461600P	2000-06-28	2000-06-28
PCT/IB2001/000995 WO2002000654A1 (en)	2000-06-28	2001-05-31	Melanocortin receptor ligands

Publications (1)

Publication Number	Publication Date
MXPA03000063A true MXPA03000063A (es)	2003-09-25

Family

ID=22799775

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03000063A MXPA03000063A (es)	2000-06-28	2001-05-31	Ligandos para receptores de malanocortina.

Country Status (26)

Country	Link
US (1)	US20020072604A1 (es)
EP (1)	EP1294719A1 (es)
JP (1)	JP2004501917A (es)
KR (1)	KR20030017571A (es)
CN (1)	CN1440406A (es)
AP (1)	AP2001002196A0 (es)
AR (1)	AR030301A1 (es)
AU (1)	AU2001260548A1 (es)
BG (1)	BG107268A (es)
BR (1)	BR0111567A (es)
CA (1)	CA2412563A1 (es)
EA (1)	EA200201119A1 (es)
EC (1)	ECSP024404A (es)
IL (1)	IL152781A0 (es)
IS (1)	IS6617A (es)
MA (1)	MA26920A1 (es)
MX (1)	MXPA03000063A (es)
NO (1)	NO20026280D0 (es)
OA (1)	OA12296A (es)
PA (1)	PA8521501A1 (es)
PE (1)	PE20020208A1 (es)
PL (1)	PL360855A1 (es)
TN (1)	TNSN01097A1 (es)
UY (1)	UY26804A1 (es)
WO (1)	WO2002000654A1 (es)
ZA (1)	ZA200210277B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001264977B2 (en) *	2000-05-30	2005-04-14	Merck & Co., Inc.	Melanocortin receptor agonists
JP2005511475A (ja)	2001-03-02	2005-04-28	ブリストル−マイヤーズスクイブカンパニー	メラノコルチン受容体のモジュレーターとして有用な化合物及びそれを含む製薬組成物
US6911447B2 (en)	2001-04-25	2005-06-28	The Procter & Gamble Company	Melanocortin receptor ligands
US7456184B2 (en) *	2003-05-01	2008-11-25	Palatin Technologies Inc.	Melanocortin receptor-specific compounds
US7732451B2 (en) *	2001-08-10	2010-06-08	Palatin Technologies, Inc.	Naphthalene-containing melanocortin receptor-specific small molecule
US7718802B2 (en)	2001-08-10	2010-05-18	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific piperazine compounds
US7655658B2 (en) *	2001-08-10	2010-02-02	Palatin Technologies, Inc.	Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7354923B2 (en)	2001-08-10	2008-04-08	Palatin Technologies, Inc.	Piperazine melanocortin-specific compounds
EP1425029A4 (en)	2001-08-10	2006-06-07	Palatin Technologies Inc	PEPTIDOMIMETICS OF BIOLOGICALLY ACTIVE METALLOPEPTIDES
US10675280B2 (en)	2001-10-20	2020-06-09	Sprout Pharmaceuticals, Inc.	Treating sexual desire disorders with flibanserin
UA78974C2 (en)	2001-10-20	2007-05-10	Boehringer Ingelheim Pharma	Use of flibanserin for treating disorders of sexual desire
US7084156B2 (en)	2001-11-27	2006-08-01	Merck & Co., Inc.	2-Aminoquinoline compounds
US7026335B2 (en)	2002-04-30	2006-04-11	The Procter & Gamble Co.	Melanocortin receptor ligands
TW200504033A (en)	2002-10-23	2005-02-01	Procter & Gamble	Melanocortin receptor ligands
AU2004209505B2 (en)	2003-02-10	2009-07-23	Banyu Pharmaceutical Co., Ltd.	Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
US7727990B2 (en)	2003-05-01	2010-06-01	Palatin Technologies, Inc.	Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7727991B2 (en)	2003-05-01	2010-06-01	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific single acyl piperazine compounds
US7968548B2 (en)	2003-05-01	2011-06-28	Palatin Technologies, Inc.	Melanocortin receptor-specific piperazine compounds with diamine groups
WO2005021555A1 (ja) *	2003-08-29	2005-03-10	Takeda Pharmaceutical Company Limited	二環性ピペラジン化合物およびその用途
JP2005306839A (ja) *	2003-08-29	2005-11-04	Takeda Chem Ind Ltd	二環性ピペラジン化合物およびその用途
RU2407785C2 (ru) *	2004-04-08	2010-12-27	Астеллас Фарма Инк.	Соединение ws727713
US7709484B1 (en)	2004-04-19	2010-05-04	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific piperazine compounds
EP3925614A3 (en) *	2005-07-08	2022-03-23	Ipsen Pharma	Melanocortin receptor ligands
WO2007014929A1 (en)	2005-08-03	2007-02-08	Boehringer Ingelheim International Gmbh	Use of flibanserin in the treatment of obesity
JP2009513604A (ja)	2005-10-29	2009-04-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
PE20080145A1 (es)	2006-03-21	2008-02-11	Janssen Pharmaceutica Nv	Tetrahidro-pirimidoazepinas como moduladores de trpv1
WO2008000760A1 (en)	2006-06-30	2008-01-03	Boehringer Ingelheim International Gmbh	Flibanserin for the treatment of urinary incontinence and related diseases
US20100004249A1 (en) *	2006-07-11	2010-01-07	Takahiro Matsumoto	Bicyclic heterocyclic compound and use thereof
US7834017B2 (en)	2006-08-11	2010-11-16	Palatin Technologies, Inc.	Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
BRPI0716439B8 (pt)	2006-08-14	2021-05-25	Boehringer Ingelheim Int	sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
BRPI0716436B8 (pt)	2006-08-25	2021-05-25	Boehringer Ingelheim Int	sistema de liberação controlada e método para fabricação do mesmo
CA2689016C (en)	2007-05-25	2014-08-12	Ipsen Pharma S.A.S.	Melanocortin receptor ligands modified with hydantoin
PE20091188A1 (es)	2007-09-12	2009-08-31	Boehringer Ingelheim Int	Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
CL2008003749A1 (es)	2007-12-17	2010-01-15	Janssen Pharmaceutica Nv	Compuestos derivados de imidazol, oxazol, y tiazol pirimidina, moduladores de trpv1, proceso de preparacion, composicion farmaceutica y su uso en el tratamiento de enfermedades, trastornos o condicion de dolor, prurito, artritis, tos, asma, trastorno del oido interno y enfermedad inflamatoria intestinal, entre otras.
AU2024273541A1 (en) *	2023-05-16	2025-11-06	Scohia Pharma, Inc.	Melanocortin 2-type receptor antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3768799A (en) *	1998-04-28	1999-11-16	Trega Biosciences, Inc.	Isoquinoline compound melanocortin receptor ligands and methods of using same
CA2334551A1 (en) *	1998-06-11	1999-12-16	Merck & Co., Inc.	Spiropiperidine derivatives as melanocortin receptor agonists
WO2000074679A1 (en) *	1999-06-04	2000-12-14	Merck & Co., Inc.	Substituted piperidines as melanocortin-4 receptor agonists

2001
- 2001-05-31 JP JP2002505778A patent/JP2004501917A/ja not_active Withdrawn
- 2001-05-31 AP APAP/P/2001/002196A patent/AP2001002196A0/en unknown
- 2001-05-31 PL PL36085501A patent/PL360855A1/xx not_active Application Discontinuation
- 2001-05-31 EA EA200201119A patent/EA200201119A1/ru unknown
- 2001-05-31 CA CA002412563A patent/CA2412563A1/en not_active Abandoned
- 2001-05-31 AU AU2001260548A patent/AU2001260548A1/en not_active Abandoned
- 2001-05-31 IL IL15278101A patent/IL152781A0/xx unknown
- 2001-05-31 CN CN01812163A patent/CN1440406A/zh active Pending
- 2001-05-31 WO PCT/IB2001/000995 patent/WO2002000654A1/en not_active Ceased
- 2001-05-31 MX MXPA03000063A patent/MXPA03000063A/es unknown
- 2001-05-31 KR KR1020027017822A patent/KR20030017571A/ko not_active Ceased
- 2001-05-31 BR BR0111567-7A patent/BR0111567A/pt not_active IP Right Cessation
- 2001-05-31 OA OA1200200389A patent/OA12296A/en unknown
- 2001-05-31 EP EP01934254A patent/EP1294719A1/en not_active Withdrawn
- 2001-06-25 US US09/891,026 patent/US20020072604A1/en not_active Abandoned
- 2001-06-26 AR ARP010103037A patent/AR030301A1/es unknown
- 2001-06-26 PE PE2001000626A patent/PE20020208A1/es not_active Application Discontinuation
- 2001-06-27 TN TNTNSN01097A patent/TNSN01097A1/fr unknown
- 2001-06-27 UY UY26804A patent/UY26804A1/es not_active Application Discontinuation
- 2001-06-28 PA PA20018521501A patent/PA8521501A1/es unknown
2002
- 2002-11-12 BG BG107268A patent/BG107268A/xx unknown
- 2002-11-14 IS IS6617A patent/IS6617A/is unknown
- 2002-12-19 ZA ZA200210277A patent/ZA200210277B/en unknown
- 2002-12-24 MA MA26976A patent/MA26920A1/fr unknown
- 2002-12-26 EC EC2002004404A patent/ECSP024404A/es unknown
- 2002-12-30 NO NO20026280A patent/NO20026280D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1440406A (zh)	2003-09-03
WO2002000654A1 (en)	2002-01-03
NO20026280L (no)	2002-12-30
PA8521501A1 (es)	2002-10-24
PL360855A1 (en)	2004-09-20
BG107268A (en)	2003-06-30
OA12296A (en)	2006-05-12
EA200201119A1 (ru)	2003-06-26
US20020072604A1 (en)	2002-06-13
ECSP024404A (es)	2003-02-06
ZA200210277B (en)	2003-12-19
JP2004501917A (ja)	2004-01-22
MA26920A1 (fr)	2004-12-20
EP1294719A1 (en)	2003-03-26
KR20030017571A (ko)	2003-03-03
AP2001002196A0 (en)	2002-12-21
UY26804A1 (es)	2002-01-31
TNSN01097A1 (fr)	2005-11-10
IS6617A (is)	2002-11-14
PE20020208A1 (es)	2002-03-13
CA2412563A1 (en)	2002-01-03
NO20026280D0 (no)	2002-12-30
AU2001260548A1 (en)	2002-01-08
IL152781A0 (en)	2003-06-24
AR030301A1 (es)	2003-08-20
BR0111567A (pt)	2003-05-06

Publication	Publication Date	Title
MXPA03000063A (es)	2003-09-25	Ligandos para receptores de malanocortina.
PL355912A1 (en)	2004-05-31	Novel compounds
WO2002036562A3 (en)	2003-01-23	1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
MXPA02012712A (es)	2003-04-25	N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas.
BG106585A (en)	2003-03-31	Kinase inhibitors as therapeutic agents
AP2002002637A0 (en)	2002-09-30	Novel piperazine
ZA9410339B (en)	1996-06-28	Diazabicyclic neurokinin antagonists
MY135841A (en)	2008-07-31	Novel benzodioxoles
ZA200202518B (en)	2003-08-27	Certain alkylene diamine-substituted heterocycles.
DE60129154D1 (de)	2007-08-09	Neuartige verbindungen
WO2002051832A3 (en)	2002-09-06	Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
WO2000067847A3 (de)	2001-08-02	Verwendung von dopamin-d3-rezeptorliganden zur herstellung von arzneimittel für die behandlung von nierenfunktionsstörungen
AP2001002306A0 (en)	2001-12-31	Bridged piperazine derivatives.
AP9701075A0 (en)	1997-10-31	Spirocyclic dopamine receptor subtype ligands.
MXPA04003544A (es)	2004-07-22	Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina.
WO2006050861A3 (en)	2006-08-10	Statine derivatives for the treatment of alzheimer's disease
AP2002002595A0 (en)	2002-09-30	Heterocyclic amide derivatives.
HK1042090A1 (zh)	2002-08-02	N-取代的具有5-羟色胺能活性的酰亚胺衍生物
BG105247A (en)	2001-11-30	N-substituted azabicycloheptane derivatives, production and use thereof
EE200200215A (et)	2003-06-16	2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks
DOP2001000174A (es)	2002-05-15	Ligandos para receptores de melanocortina
SI1358182T1 (en)	2005-02-28	Diazocine derivates and their use as tryptase inhibitors
MY141461A (en)	2010-04-30	N-ureidoalkyl-piperidines as modulators of chemokine receptor activity